Bayer begins phase II study of investigational GIRK4 inhibitor in patients with atrial fibrillation: Berlin Thursday, September 10, 2026, 10:00 Hrs [IST] Bayer announced the initi ...

Bayer announced today the initiation of a global Phase II clinical trial ( NCT07625215) evaluating BAY 3670549, an investigational highly selective G-protein-coupled inwardly rectifying potassium ...

Updated AHA and ASA guidelines emphasize interprofessional care and inpatient rehabilitation facilities for poststroke recovery.

Kyler Murray left his debut with the Minnesota Vikings on Sunday and was placed in the NFL’s concussion protocol after taking ...

In the first hours after a severe spinal cord injury, Jonathan Yun, MD, is trying to control what can still be controlled: blood pressure, oxygenation, blood loss, the stability of the patient, and ...

UP TO 50 million men in the U.S. have erectile dysfunction, and it’s a condition that gets more common with age. Some pop a ...

Northwestern Medicine has completed 25 awake kidney transplants using spinal anesthesia. The program allows patients allergic ...

The FDA approval of etripamil for PSVT occurred in December, 2025. Investigation about a potential role of etripamil in ...